ACROBiosystems is an internationally recognized manufacturer of recombinant proteins committed to supporting cancer immunotherapy. The core technology platforms focus on mammalian cell-based recombinant protein production and process development. We have multiple offices and branches in North America, Europe, and Asia, and we are proud of serving customers from over 50 countries.